David Foggy is the Founder and Chief Executive of Denver-based October Biosciences, which specializes in nano-encapsulated CBD (nCBD™) products formulated for maximum bioavailability.
After spending over a decade working for tech companies such as Sun Microsystems, Intel, Lockheed Martin, and SpaceX, to name a few, David has come to know what drives disruptive innovation and how to lead it.
For 3+ years at Citizens Laboratories, David led a small team of scientists researching and designing a subcritical water extraction system for the extraction of cannabinoids from industrial hemp. Much was learned and achieved on this project but a critical inflection point was reached. As a result, David has recently shifted the focus of his team and added business and marketing talent for the sole purpose of producing consumer-facing, nano-encapsulated, hemp-based cannabinoid products.
David holds a BS from San Francisco State University and PhD in Computation from The University of Manchester.